LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K021071
    Device Name
    PCCS GRAFT DELIVERY SYSTEM
    Manufacturer
    BIOMET, INC.
    Date Cleared
    2002-07-01

    (90 days)

    Product Code
    FMF
    Regulation Number
    880.5860
    Type
    Traditional
    Panel
    General Hospital
    Reference & Predicate Devices
    K994148,K930321,K980580,K003286,K011032,K012868
    Why did this record match?
    Reference Devices :

    K994148,K930321,K95064,K980580

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    This device is intended for use in the delivery of allograft and autograft bone materials to an orthopedic surgical site. In addition, it is designed to facilitate pre-mixing of bone graft materials with I.V. fluids, blood, plasma, platelet rich plasma, bone marrow or other specific blood components as deemed necessary by the clinical use requirements.

    Device Description

    The Graft Delivery System will be configured using the following components. See Exhibit 1 for drawings and supplier catalog Information.

    • . Two commercially available disposable medical piston syringes
    • Applicator tips .
      This Graft Delivery System will be sold in coniunction with CelSep® Centrifuge System (K994148), CelSep® Centrifuge System (K994148) that consists of a compact bench top centrifuge designed for multi-purpose use in medical, industrial, and scientific laboratories, that includes a single-use processing disposable.
    AI/ML Overview

    The provided text describes a 510(k) premarket notification for a "Graft Delivery System" (piston syringe). This submission focuses on demonstrating substantial equivalence to predicate devices, rather than presenting a study with specific acceptance criteria and performance metrics for a new, standalone device.

    Therefore, the requested information (acceptance criteria, device performance tables, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, ground truth types, training set details) cannot be extracted from the provided document.

    The document states:

    • "No performance standards have been developed for this type of device." (Page 1)
    • The primary method for clearance is establishing "Substantial Equivalence" to existing predicate devices (Page 2).

    The core of the submission is a comparison table showing that the "Graft Delivery System" has the "Same" intended use, components, sterility, and principle of operation as its predicate devices (DePuy/AcroMed Symphony and Harvest Technologies SmartJet). The only difference noted for Osseous Technologies and DePuy AcroMed is the specific centrifuge system with which they are commercially available/labeled.

    This type of submission focuses on demonstrating that the new device is as safe and effective as already legally marketed devices, rather than providing detailed performance studies against defined acceptance criteria.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1